PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE DMAC — DIAMEDICA THERAPEUTICS INC

Ownership history in PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE  ·  12 quarters on record

AI Ownership Summary

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported DIAMEDICA THERAPEUTICS INC (DMAC) in 12 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 14.39% in 2025 Q4. The latest visible filing shows DMAC at 8.05% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this DMAC ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's position in DIAMEDICA THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

DMAC was reported at 8.05% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
14.39% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

DMAC stock page PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE fund profile PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE full holdings
How PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE held DMAC — position size vs. price
% of Fund (quarterly)    DMAC price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 875,000 — 0% 8.05% $5.9M 2026-05-15 $6.06
2025 Q4 UNCHANGED — — — 875,000 — 0% 14.39% $7.0M 2026-02-12 $8.63
2025 Q3 ADDED — — — 875,000 +225,000 +34.6% 10.72% $6.0M 2025-11-12 $6.31
2025 Q2 ADDED — — — 650,000 +50,000 +8.3% 4.03% $2.5M 2025-08-13 $6.00
2025 Q1 ADDED — — — 600,000 +85,216 +16.6% 5.33% $2.3M 2025-05-13 $3.98
2024 Q4 ADDED — — — 514,784 +32,170 +6.7% 6.46% $2.8M 2025-02-12 $6.28
2024 Q3 UNCHANGED — — — 482,614 — 0% 3.63% $2.0M 2024-11-14 $4.12
2024 Q2 REDUCED — — — 482,614 -17,386 -3.5% 3.48% $1.4M 2024-08-13 $3.58
2024 Q1 UNCHANGED — — — 500,000 — 0% 2.47% $1.4M 2024-05-14 $3.02
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding DMAC

As of 2026 Q2 — sorted by position size

COOPERMAN LEON G 3Y 7Y 0.68% Bleichroeder LP 3Y 0.48% COBALT CAPITAL MANAGEMENT, INC. 3Y 7Y 0.45% MEMBERS WEALTH LLC 0.39% Corient IA LP 0.23% MAGNOLIA CAPITAL ADVISORS LLC 3Y 0.09% Diametric Capital, LP 3Y 7Y 0.06% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.03% Private Capital Management, LLC 3Y 7Y 0.03% CATALYST FINANCIAL PARTNERS LLC 3Y 0.03%

FAQ About PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE and DMAC

These are the practical questions this page is built to answer before you even open the full history table.

How long has PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported owning DMAC?

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported DMAC across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported DMAC position in PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's portfolio?

The largest reported portfolio weight for DMAC was 14.39% in 2025 Q4.

What is the latest reported DMAC position on this page?

The most recent filing on this page is 2026 Q1, when PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported 875,000 shares, equal to 8.05% of portfolio, with an estimated market value of $5.9M.

What does the chart on this DMAC ownership page compare?

The chart compares PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's quarterly DMAC portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE time their DMAC position?

Based on 13F filing dates vs. subsequent DMAC price moves, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE correctly timed 5 out of 8 reported position changes (62%). The annualised alpha on DMAC relative to SPY over the holding period was +8.5%.

← Back to PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE Holdings